Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023
“The oncology nutrition market is projected to grow at a CAGR of 8.7% between 2018 and 2023.”
The oncology nutrition market is expected to reach USD 2.21 billion by 2023 from USD 1.46 billion in 2018, at a CAGR of 8.7%. The overall growth of the market is largely driven by the shifting focus from parenteral to enteral nutrition, increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions. The development of elemental formulas and product innovation in this field also provides significant growth opportunities in this market. However, the complications associated with tube feeding and limited reimbursement represent significant challenges to the market growth.
“The head and neck cancers segment is expected to grow at the fastest rate during the forecast period.”
Based on cancer type, the oncology nutrition market is segmented into head & neck cancers, stomach & gastrointestinal cancers, pancreatic cancer, liver cancer, esophageal cancer, lung cancer, breast cancer, blood cancer, and other cancers. The head & neck cancers segment is expected to grow at the highest CAGR during the forecast period. This is primarily attributed to the increasing incidence of head and neck cancers across the globe. Such patients see the major use of feeding formulas as severe conditions such as mucositis, xerostomia, dysgeusia, nausea, and vomiting limit their nutritional intake.
“APAC to witness the highest growth during the forecast period.”
Geographically, the oncology nutrition market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2017, North America commanded a major share of the oncology nutrition market. However, Asia Pacific is expected to witness the highest growth during the forecast period. The significant growth of the Asia Pacific market is mainly attributed to the growing prevalence of chronic diseases & disorders, increasing number of preterm births, rising geriatric population, and increasing healthcare expenditure.
Break of primary participants:
Research Coverage:
The report analyzes the various types of nutritional formulas for cancer in the market and their adoption patterns. It aims at estimating the market size and future growth potential of the oncology nutrition market for different cancer types and region. The report also includes in-depth company profiles of the key players in this market along with their product offerings, recent developments, and market strategies.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned four strategies for strengthening their market position.
The report provides insights on the following pointers:
The oncology nutrition market is expected to reach USD 2.21 billion by 2023 from USD 1.46 billion in 2018, at a CAGR of 8.7%. The overall growth of the market is largely driven by the shifting focus from parenteral to enteral nutrition, increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions. The development of elemental formulas and product innovation in this field also provides significant growth opportunities in this market. However, the complications associated with tube feeding and limited reimbursement represent significant challenges to the market growth.
“The head and neck cancers segment is expected to grow at the fastest rate during the forecast period.”
Based on cancer type, the oncology nutrition market is segmented into head & neck cancers, stomach & gastrointestinal cancers, pancreatic cancer, liver cancer, esophageal cancer, lung cancer, breast cancer, blood cancer, and other cancers. The head & neck cancers segment is expected to grow at the highest CAGR during the forecast period. This is primarily attributed to the increasing incidence of head and neck cancers across the globe. Such patients see the major use of feeding formulas as severe conditions such as mucositis, xerostomia, dysgeusia, nausea, and vomiting limit their nutritional intake.
“APAC to witness the highest growth during the forecast period.”
Geographically, the oncology nutrition market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2017, North America commanded a major share of the oncology nutrition market. However, Asia Pacific is expected to witness the highest growth during the forecast period. The significant growth of the Asia Pacific market is mainly attributed to the growing prevalence of chronic diseases & disorders, increasing number of preterm births, rising geriatric population, and increasing healthcare expenditure.
Break of primary participants:
- By Company Type – Tier 1: 48%, Tier 2–34%, and Tier 3–18%
- By Designation – C-suite: 32%, Director and Manager Level: 48%, and Executives and Others: 20%
- By Region – North America: 36%, Europe: 27%, Asia Pacific: 21%, and the Rest of the World: 16%
Research Coverage:
The report analyzes the various types of nutritional formulas for cancer in the market and their adoption patterns. It aims at estimating the market size and future growth potential of the oncology nutrition market for different cancer types and region. The report also includes in-depth company profiles of the key players in this market along with their product offerings, recent developments, and market strategies.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned four strategies for strengthening their market position.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the oncology nutrition market
- Product Development/Innovation: Detailed insights on the research and development activities and new product launches in the oncology nutrition market
- Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the oncology nutrition market
- Competitive Assessment: In-depth assessment of growth strategies, products, and manufacturing capabilities of leading players in the oncology nutrition market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET COVERED
1.3 MARKET DEFINITION
1.4 YEARS CONSIDERED
2 RESEARCH METHODOLOGY
2.1 SECONDARY RESEARCH
2.2 PRIMARY RESEARCH
2.3 ANALYSIS
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
4 INDUSTRY INSIGHTS
4.1 CLINICAL CHALLENGES
4.2 MARKET CHALLENGES
4.3 PRODUCT ATTRIBUTES ASSESSMENT
4.4 INSIGHTS OF INDUSTRY EXPERTS
5 GLOBAL ONCOLOGY NUTRITIONAL FEEDING FORMULAS MARKET, BY CANCER TYPE
5.1 OVERVIEW – CANCER
5.2 MARKET SIZE, BY CANCER TYPE
5.3 HEAD AND NECK CANCER
5.4 STOMACH AND GASTROINTESTINAL CANCERS
5.5 LIVER CANCER
5.6 PANCREATIC CANCER
5.7 ESOPHAGEAL CANCER
5.8 LUNG CANCER
5.9 BREAST CANCER
5.10 BLOOD CANCER
5.11 OTHER CANCERS
6 PRODUCT PORTFOLIO ASSESSMENT
7 COMPANY PROFILES
(Business Overview, Company Snapshot, Financial Review, Products Offered, Recent Developments, MnM View)
7.1 ABBOTT LABORATORIES
7.2 NESTLÉ
7.3 DANONE
7.4 FRESENIUS KABI
7.5 B. BRAUN
8 MARKET SHARE ANALYSIS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET COVERED
1.3 MARKET DEFINITION
1.4 YEARS CONSIDERED
2 RESEARCH METHODOLOGY
2.1 SECONDARY RESEARCH
2.2 PRIMARY RESEARCH
2.3 ANALYSIS
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
4 INDUSTRY INSIGHTS
4.1 CLINICAL CHALLENGES
4.2 MARKET CHALLENGES
4.3 PRODUCT ATTRIBUTES ASSESSMENT
4.4 INSIGHTS OF INDUSTRY EXPERTS
5 GLOBAL ONCOLOGY NUTRITIONAL FEEDING FORMULAS MARKET, BY CANCER TYPE
5.1 OVERVIEW – CANCER
5.2 MARKET SIZE, BY CANCER TYPE
5.3 HEAD AND NECK CANCER
5.4 STOMACH AND GASTROINTESTINAL CANCERS
5.5 LIVER CANCER
5.6 PANCREATIC CANCER
5.7 ESOPHAGEAL CANCER
5.8 LUNG CANCER
5.9 BREAST CANCER
5.10 BLOOD CANCER
5.11 OTHER CANCERS
6 PRODUCT PORTFOLIO ASSESSMENT
7 COMPANY PROFILES
(Business Overview, Company Snapshot, Financial Review, Products Offered, Recent Developments, MnM View)
7.1 ABBOTT LABORATORIES
7.2 NESTLÉ
7.3 DANONE
7.4 FRESENIUS KABI
7.5 B. BRAUN
8 MARKET SHARE ANALYSIS
LIST OF TABLES
Table 1 GLOBAL ONCOLOGY NUTRITIONAL FEEDING FORMULAS MARKET, BY CANCER TYPE, 2016–2023 (USD MILLION)
Table 2 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 3 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR HEAD & NECK CANCERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 4 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR STOMACH & GASTROINTESTINAL CANCERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 5 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR LIVER CANCER, BY COUNTRY, 2016–2023 (USD MILLION)
Table 6 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR PANCREATIC CANCER, BY COUNTRY, 2016–2023 (USD MILLION)
Table 7 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR ESOPHAGEAL CANCER, BY COUNTRY, 2016–2023 (USD MILLION)
Table 8 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR LUNG CANCER, BY COUNTRY, 2016–2023 (USD MILLION)
Table 9 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR BREAST CANCER, BY COUNTRY, 2016–2023 (USD MILLION)
Table 10 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR BLOOD CANCER, BY COUNTRY, 2016–2023 (USD MILLION)
Table 11 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR OTHER CANCERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 1 GLOBAL ONCOLOGY NUTRITIONAL FEEDING FORMULAS MARKET, BY CANCER TYPE, 2016–2023 (USD MILLION)
Table 2 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 3 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR HEAD & NECK CANCERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 4 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR STOMACH & GASTROINTESTINAL CANCERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 5 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR LIVER CANCER, BY COUNTRY, 2016–2023 (USD MILLION)
Table 6 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR PANCREATIC CANCER, BY COUNTRY, 2016–2023 (USD MILLION)
Table 7 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR ESOPHAGEAL CANCER, BY COUNTRY, 2016–2023 (USD MILLION)
Table 8 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR LUNG CANCER, BY COUNTRY, 2016–2023 (USD MILLION)
Table 9 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR BREAST CANCER, BY COUNTRY, 2016–2023 (USD MILLION)
Table 10 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR BLOOD CANCER, BY COUNTRY, 2016–2023 (USD MILLION)
Table 11 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR OTHER CANCERS, BY COUNTRY, 2016–2023 (USD MILLION)
LIST OF FIGURES
Figure 1 GLOBAL CANCER INCIDENCE, 2008–2030
Figure 2 CANCER INCIDENCE ACROSS KEY COUNTRIES, 2012
Figure 3 SHARE OF GERIATRIC POPULATION AMONG NEW CANCER CASES
Figure 4 SMOKING PREVALENCE, BY COUNTRY, 2015 (% OF TOTAL POPULATION)
Figure 5 ESTIMATED NUMBER OF NEW CANCER CASES
Figure 6 GLOBAL ONCOLOGY NUTRITIONAL FEEDING FORMULAS MARKET, BY CANCER TYPE, 2018 VS 2023
Figure 7 HEAD & NECK CANCERS INCIDENCE, 2012–2030
Figure 8 HEAD & NECK CANCERS INCIDENCE ACROSS KEY REGIONS, 2012
Figure 9 STOMACH CANCER INCIDENCE, 2012–2030
Figure 10 STOMACH CANCER INCIDENCE ACROSS KEY REGIONS, 2012
Figure 11 LIVER CANCER INCIDENCE, 2012–2030
Figure 12 LIVER CANCER INCIDENCE ACROSS KEY REGIONS, 2012
Figure 13 PANCREATIC CANCER INCIDENCE, 2012–2030
Figure 14 PANCREATIC CANCER INCIDENCE ACROSS KEY REGIONS, 2012
Figure 15 ESOPHAGEAL CANCER INCIDENCE, 2012–2030
Figure 16 ESOPHAGEAL CANCER INCIDENCE ACROSS KEY REGIONS, 2012
Figure 17 LUNG CANCER INCIDENCE, 2012–2030
Figure 18 LUNG CANCER INCIDENCE ACROSS KEY REGIONS, 2012
Figure 19 BREAST CANCER INCIDENCE, 2012–2030
Figure 20 BREAST CANCER INCIDENCE ACROSS KEY REGIONS, 2012
Figure 21 BLOOD CANCER INCIDENCE, 2012–2030
Figure 22 BLOOD CANCER INCIDENCE ACROSS KEY REGIONS, 2012
Figure 23 NUTRITIONAL FEEDING FORMULAS: MARKET SHARE ASSESSMENT, 2015 VS 2017 VS 2023
Figure 1 GLOBAL CANCER INCIDENCE, 2008–2030
Figure 2 CANCER INCIDENCE ACROSS KEY COUNTRIES, 2012
Figure 3 SHARE OF GERIATRIC POPULATION AMONG NEW CANCER CASES
Figure 4 SMOKING PREVALENCE, BY COUNTRY, 2015 (% OF TOTAL POPULATION)
Figure 5 ESTIMATED NUMBER OF NEW CANCER CASES
Figure 6 GLOBAL ONCOLOGY NUTRITIONAL FEEDING FORMULAS MARKET, BY CANCER TYPE, 2018 VS 2023
Figure 7 HEAD & NECK CANCERS INCIDENCE, 2012–2030
Figure 8 HEAD & NECK CANCERS INCIDENCE ACROSS KEY REGIONS, 2012
Figure 9 STOMACH CANCER INCIDENCE, 2012–2030
Figure 10 STOMACH CANCER INCIDENCE ACROSS KEY REGIONS, 2012
Figure 11 LIVER CANCER INCIDENCE, 2012–2030
Figure 12 LIVER CANCER INCIDENCE ACROSS KEY REGIONS, 2012
Figure 13 PANCREATIC CANCER INCIDENCE, 2012–2030
Figure 14 PANCREATIC CANCER INCIDENCE ACROSS KEY REGIONS, 2012
Figure 15 ESOPHAGEAL CANCER INCIDENCE, 2012–2030
Figure 16 ESOPHAGEAL CANCER INCIDENCE ACROSS KEY REGIONS, 2012
Figure 17 LUNG CANCER INCIDENCE, 2012–2030
Figure 18 LUNG CANCER INCIDENCE ACROSS KEY REGIONS, 2012
Figure 19 BREAST CANCER INCIDENCE, 2012–2030
Figure 20 BREAST CANCER INCIDENCE ACROSS KEY REGIONS, 2012
Figure 21 BLOOD CANCER INCIDENCE, 2012–2030
Figure 22 BLOOD CANCER INCIDENCE ACROSS KEY REGIONS, 2012
Figure 23 NUTRITIONAL FEEDING FORMULAS: MARKET SHARE ASSESSMENT, 2015 VS 2017 VS 2023
